| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/10/2014 | DE102012019882A1 Peptide zur Behandlung und Frühdiagnose von Morbus Alzheimer und anderer Tauopathien Peptides for the treatment and early diagnosis of Alzheimer's disease and other tauopathies |
| 04/09/2014 | EP2716656A1 Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof |
| 04/09/2014 | EP2716652A1 Anti-fatty acid synthase polypeptide and use thereof |
| 04/09/2014 | EP2716299A2 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
| 04/09/2014 | EP2714971A1 Method of determining, identifying or isolating cell-penetrating peptides |
| 04/09/2014 | EP2714727A1 High affinity sumo traps |
| 04/09/2014 | EP2714720A1 A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| 04/09/2014 | EP2714719A2 Dispersion and detachment of cell aggregates |
| 04/09/2014 | EP2714718A2 Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
| 04/09/2014 | EP2714717A1 Phoenixin peptides |
| 04/09/2014 | EP2713729A2 Synergistic combinations of polyene fungicides and non-ribosomal peptides and related methods of use |
| 04/09/2014 | CN103713137A Arginine vasopressin pro-hormone as predictive biomarker for diabetes |
| 04/09/2014 | CN103710019A Preparation method and purpose of polypeptide modified CdTe quantum dot |
| 04/09/2014 | CN103709235A Method for reducing solvent use amount and extracting high-purity enramycin |
| 04/09/2014 | CN103709234A FVIII peptides and their use in tolerising haemophiliacs |
| 04/09/2014 | CN103709233A Fmoc-strategy solid-phase synthesis method of thymopentin |
| 04/09/2014 | CN103709232A Polypeptide capable of inhibiting human immunodeficiency virus infection activity, and related bacteriophage |
| 04/09/2014 | CN102875657B Method for preparing telomerase polypeptide vaccine |
| 04/09/2014 | CN101845079B Hexapeptide or derivative thereof and medical application thereof |
| 04/08/2014 | US8691949 Peptide having anti-diabetic activity and use thereof |
| 04/08/2014 | US8691947 Materials related to sodium/potassium adenosine triphosphatase and Src |
| 04/08/2014 | US8691946 Methods and compositions for soft tissue repair |
| 04/08/2014 | US8691943 Antimicrobial activity of chicken NK-2 peptide against apicomplexan protozoa |
| 04/08/2014 | US8691941 Method for producing peptide |
| 04/08/2014 | US8691772 HSP60, HSP60 peptides and T cell vaccines for immunomodulation |
| 04/08/2014 | US8691770 Method for processing microbiologically produced cyclic oligopeptides |
| 04/08/2014 | US8691760 Peptides, pharmaceutical compositions comprising same and uses thereof |
| 04/08/2014 | US8691758 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/08/2014 | US8691195 Peptide having activity of transforming growth factor and production method therefor |
| 04/08/2014 | US8691189 Method of colorectal cancer detection by using radiolabeled anti-GRP78 peptide |
| 04/08/2014 | CA2492053C Peptides with antimicrobial properties and compounds containing same, particularly for preserving food |
| 04/03/2014 | WO2014052647A2 Proline-locked stapled peptides and uses thereof |
| 04/03/2014 | WO2014047822A1 Method for preparation of buserelin |
| 04/03/2014 | WO2013192238A3 Compositions and methods for treatment of diabetes |
| 04/03/2014 | WO2012051581A3 Intestinal peptide targeting ligands |
| 04/03/2014 | US20140094586 Hla-binding peptide, and dna fragment and recombinant vector coding for said hla-binding peptide |
| 04/03/2014 | US20140094415 High-affinity, dimeric inhibitors of psd-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain |
| 04/03/2014 | US20140094414 Composition for preventing or treating neurodegenerative disease including bioactive peptide as effective component |
| 04/03/2014 | US20140094412 Selective alfavbeta3 receptor peptide antagonist for therapeutic and diagnostic applications |
| 04/03/2014 | US20140094409 Antagonist for (pro)renin receptor for the treatment of hypertension and diabetes |
| 04/03/2014 | US20140094404 Methods and reagents for efficient and targeted delivery of therapeutic molecules to cxcr4 cells |
| 04/03/2014 | US20140094403 Enopeptins, uses thereof, and methods of synthesis thereto |
| 04/03/2014 | US20140094402 Lantibiotic NAI-802, Pharmaceutically Acceptable Salts, Compositions and Uses Thereof |
| 04/03/2014 | US20140094400 Novel Angiotensin Type 2 (AT2) Receptor Agonists and Uses Thereof |
| 04/03/2014 | US20140093892 Marker comprising anti-ck8/18 complex autoantibody and its use for diagnosing cancer |
| 04/03/2014 | US20140093526 Preparation of Neutralizing Antibody to Human Herpesvirus 6 Glycoprotein Q1 and Analysis Thereof |
| 04/03/2014 | US20140093521 Therapeutic dll4 binding proteins |
| 04/03/2014 | US20140093473 Amphiphilic linear peptidepeptoid and hydrogel comprising the same |
| 04/03/2014 | DE102012105193B4 Stimulation der zellulären Immunantwort gegen das Epstein-Barr-Virus (EBV) Stimulation of the cellular immune response against the Epstein-Barr virus (EBV) |
| 04/02/2014 | EP2712357A1 Modified tyrosine amino acids, peptides containing them, and their use for detecting hydrolase enzyme activity |
| 04/02/2014 | CN1950394B Method for inhibiting immune complex formation in a subjetc |
| 04/02/2014 | CN103703018A Beta-hairpin peptidomimetics as CXC4 antagonists |
| 04/02/2014 | CN103703017A A process for extraction of peptides and its application in liquid phase peptide synthesis |
| 04/02/2014 | CN103703016A Phoenixin peptides |
| 04/02/2014 | CN103702723A Fire extinguishing agent and fire extinguishing method using same |
| 04/02/2014 | CN103694351A Inhibitors of receptor tyrosine kinases and methods of use thereof |
| 04/02/2014 | CN103694320A Preparation method of plecanatide |
| 04/02/2014 | CN103694319A Buserelin purification method |
| 04/02/2014 | CN103694318A EV71 (Enterovirus 71) VP1 and RdRp (RNA dependent RNA polymerase) protein specific T cell epitope peptide as well as application thereof |
| 04/02/2014 | CN103694317A Cationic polypeptide, polypeptide-based siRNA gene transfection reagent and preparation method thereof |
| 04/02/2014 | CN103694316A Preparation method of argireline |
| 04/02/2014 | CN103694315A Cdc45l peptides and vaccines including the same |
| 04/02/2014 | CN102690326B Novel gossypol derivate with anti-HIV activity and preparation method thereof |
| 04/02/2014 | CN102336818B Peptide substance crystal B and preparation method and use thereof |
| 04/02/2014 | CN102241742B Peptides and compounds that bind to a thrombopoietin receptor |
| 04/02/2014 | CN102199195B Half-path charge matching amphiphilic self assembling short peptide, and application thereof as nanometer hemostatic material and hydrophobic drug carrier |
| 04/02/2014 | CN101808660B Vaccine peptide combinations against cat allergy |
| 04/01/2014 | US8686113 Antibiotic peptides |
| 04/01/2014 | US8685955 Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| 04/01/2014 | US8685927 Cosmetic and/or pharmaceutical composition comprising a relieving peptidic hydrolyzate |
| 04/01/2014 | US8685926 Compositions and method for CaMKII inhibitors and uses thereof |
| 04/01/2014 | US8685922 Template-fixed peptidomimetics with antimicrobial activity |
| 04/01/2014 | US8685921 Inhibitors of beta integrin-G protein alpha subunit binding interactions |
| 04/01/2014 | US8685399 PAX 5 monoclonal antibody |
| 04/01/2014 | US8685398 Chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/01/2014 | US8685372 Peptides and aptamers for targeting of neuron or nerves |
| 04/01/2014 | CA2597191C Antimicrobial hexapeptides |
| 04/01/2014 | CA2493928C Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
| 04/01/2014 | CA2488682C Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/27/2014 | WO2014046481A1 Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate |
| 03/27/2014 | WO2014045310A1 Pyrimido[5,4-d]pyrimidine or pyrimidine derivatives compounds and uses thereof in the treatment of cancer |
| 03/27/2014 | WO2014044803A1 Method for producing a cyclic peptide |
| 03/27/2014 | WO2014043861A1 Use of pedf-derived polypeptides for preventing and/or ameliorating skin aging |
| 03/27/2014 | WO2013170077A3 V1a receptor agonists |
| 03/27/2014 | US20140088290 Novel Melanoma Antigen Peptide and Uses Thereof |
| 03/27/2014 | US20140088023 sGCalpha1 Inhibiting Compositions, and Methods of Treatment of Cancers Therewith |
| 03/27/2014 | US20140088022 Novel Solid Materials of and Methods for Obtaining Them |
| 03/27/2014 | US20140088017 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same |
| 03/27/2014 | US20140088006 Stem Cell Mobilization and Tissue Repair and Regeneration |
| 03/27/2014 | US20140088003 Polymer-based sustained release device |
| 03/27/2014 | US20140087994 Template-fixed peptidomimetics with antimicrobial activity |
| 03/27/2014 | US20140087425 Methods for preparing purified lipopeptides |
| 03/27/2014 | US20140087399 Assay method for peptide specific t-cells |
| 03/27/2014 | US20140086981 Pgc-1alpha-modulating peptides |
| 03/27/2014 | US20140086945 Albumin-amyloid peptide conjugates and uses thereof |
| 03/27/2014 | US20140086943 Novel and powerful mhc-class ii peptides derived from survivin |
| 03/26/2014 | EP2711025A2 Self-assembling peptides incorporating modifications and methods of use thereof |
| 03/26/2014 | EP2710129A1 Therapeutic fusion proteins |
| 03/26/2014 | EP2710027A1 Bombesin receptor targeting peptide incorporating a 1, 2, 3-triazole group in the backbone for preparing in vivo diagnostic and therapeutic agents |
| 03/26/2014 | EP2709645A2 Improved peptide pharmaceuticals |